Trabecular bone score in rheumatic disease

Patients with rheumatic diseases (RD) are at high risk of osteoporosis (OP) and osteoporotic fractures. The Trabecular bone score (TBS) is a relatively novel method of assessing bone quality, which independently predicts fracture risk regardless of bone mineral density (BMD). A lower TBS in patients...

Full description

Bibliographic Details
Main Authors: M. V. Kozyreva, O. A. Nikitinskaya, N. V. Toroptsova
Format: Article
Language:Russian
Published: IMA PRESS LLC 2022-12-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/3248
_version_ 1797862601858744320
author M. V. Kozyreva
O. A. Nikitinskaya
N. V. Toroptsova
author_facet M. V. Kozyreva
O. A. Nikitinskaya
N. V. Toroptsova
author_sort M. V. Kozyreva
collection DOAJ
description Patients with rheumatic diseases (RD) are at high risk of osteoporosis (OP) and osteoporotic fractures. The Trabecular bone score (TBS) is a relatively novel method of assessing bone quality, which independently predicts fracture risk regardless of bone mineral density (BMD). A lower TBS in patients with RD compared to controls is shown in most studies concerning TBS and RD. The data obtained indicate that TBS predicts fractures better in RD, especially in patients receiving glucocorticoids, than BMD or the FRAX algorithm. TBS degradation has been associated with disease activity in ankylosing spondylitis, systemic sclerosis, and rheumatoid arthritis in a few studies. However, there is little data in the literature on the effect of rheumatic disease therapy and OP treatment in patients with RD on predictive ability of TBS for incident fracture.
first_indexed 2024-04-09T22:22:00Z
format Article
id doaj.art-ba2d597203ac43e896833ecc8cbbcdad
institution Directory Open Access Journal
issn 1995-4484
1995-4492
language Russian
last_indexed 2024-04-09T22:22:00Z
publishDate 2022-12-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj.art-ba2d597203ac43e896833ecc8cbbcdad2023-03-22T13:45:58ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922022-12-0160658759310.47360/1995-4484-2022-587-592861Trabecular bone score in rheumatic diseaseM. V. Kozyreva0O. A. Nikitinskaya1N. V. Toroptsova2V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyPatients with rheumatic diseases (RD) are at high risk of osteoporosis (OP) and osteoporotic fractures. The Trabecular bone score (TBS) is a relatively novel method of assessing bone quality, which independently predicts fracture risk regardless of bone mineral density (BMD). A lower TBS in patients with RD compared to controls is shown in most studies concerning TBS and RD. The data obtained indicate that TBS predicts fractures better in RD, especially in patients receiving glucocorticoids, than BMD or the FRAX algorithm. TBS degradation has been associated with disease activity in ankylosing spondylitis, systemic sclerosis, and rheumatoid arthritis in a few studies. However, there is little data in the literature on the effect of rheumatic disease therapy and OP treatment in patients with RD on predictive ability of TBS for incident fracture.https://rsp.mediar-press.net/rsp/article/view/3248trabecular bone scorefracture risk assessmentrheumatic diseaserheumatoid arthritissystemic sclerosisglucocorticoids
spellingShingle M. V. Kozyreva
O. A. Nikitinskaya
N. V. Toroptsova
Trabecular bone score in rheumatic disease
Научно-практическая ревматология
trabecular bone score
fracture risk assessment
rheumatic disease
rheumatoid arthritis
systemic sclerosis
glucocorticoids
title Trabecular bone score in rheumatic disease
title_full Trabecular bone score in rheumatic disease
title_fullStr Trabecular bone score in rheumatic disease
title_full_unstemmed Trabecular bone score in rheumatic disease
title_short Trabecular bone score in rheumatic disease
title_sort trabecular bone score in rheumatic disease
topic trabecular bone score
fracture risk assessment
rheumatic disease
rheumatoid arthritis
systemic sclerosis
glucocorticoids
url https://rsp.mediar-press.net/rsp/article/view/3248
work_keys_str_mv AT mvkozyreva trabecularbonescoreinrheumaticdisease
AT oanikitinskaya trabecularbonescoreinrheumaticdisease
AT nvtoroptsova trabecularbonescoreinrheumaticdisease